Sandra Fletcher and the neurological team that worked with her on the neuronanobot trials, every single patient had shown the same remarkable results that Rocky Stankowski displayed. By mid February, 2051, ten months after the human trials had started, thirty patients had been treated and thirty patients had been cured. The FDA felt compelled to abort the trial, and set guidelines recommending TPNT as the treatment of choice for traumatic brain injury. ___ Sandi had been so wrapped up in the details and analysis of the TPNT trials that it never occurred to her that someone else could have independently devised the techniques for producing the nanobots. The idea that someone outside of her lab would have the information necessary to apply for and receive patents for neuronanobot fabrication never crossed her mind, at least not until she attempted to file the applications herself, only to discover that they already belonged to BNI. “What!”
